We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Continuous Infusion Versus Bolus Administration of Steroids in Severe Attacks of Ulcerative Colitis: A Randomized, Double-Blind Trial.
- Authors
Bossa, Fabrizio; Fiorella, Serafina; Caruso, Nazario; Accadia, Laura; Napolitano, Grazia; Valvano, Maria Rosa; Andriulli, Angelo; Annese, Vito
- Abstract
BACKGROUND: In patients with severe attacks of ulcerative colitis (UC), IV steroids represent the first-line treatment, leading to clinical improvement in approximately 50–60% of patients. AIM: The aim of this study was to prospectively compare the efficacy and safety of different modalities of steroid administration, and to evaluate predictors of failure to therapy. MATERIALS In a single-center, double-blind trial, consecutive patients with a severe attack of UC received AND METHODS: 1 mg/kg/day of 6-methyl-prednisolone administered randomly by either a bolus injection (group A) or continuous infusion (group B). RESULTS: Sixty-six patients were enrolled (35 men, mean age 38 ± 15, range 18–75 yr), 15 of them at their first attack of UC; in the remaining cases, the mean duration of disease was 4.5 ± 5 yr. At inclusion, forty patients (60%) had pancolitis and the remainder had left-sided colitis. Overall, thirty-three patients (50%) underwent clinical remission after 7 days of treatment: 16 of 32 in group A and 17 of 34 in group B. Thirty-one patients eventually underwent total colectomy (12 in group A and 9 in group B), which was carried out by the first month in 10 patients (5 in each group). Twenty-eight patients (15 in group A and 13 in group B) experienced steroid-related adverse reactions. All differences between groups were not statistically significant. Previous use of steroids (OR 13.6, CI 2–86) and active smoking (OR 11.6, CI 1.4–107) were independent predictors of nonresponse. CONCLUSIONS: In severe attacks of UC, methyl-prednisolone given as a continuous infusion was no better than bolus administration in terms of efficacy and safety.
- Subjects
ULCERATIVE colitis; INFUSION therapy; INFLAMMATORY bowel diseases; COLON diseases; LIPIDS; STEROIDS
- Publication
American Journal of Gastroenterology (Springer Nature), 2007, Vol 102, Issue 3, p601
- ISSN
0002-9270
- Publication type
Article
- DOI
10.1111/j.1572-0241.2006.01007.x